1. Home
  2. ROAD vs GRFS Comparison

ROAD vs GRFS Comparison

Compare ROAD & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROAD
  • GRFS
  • Stock Information
  • Founded
  • ROAD 2001
  • GRFS 1940
  • Country
  • ROAD United States
  • GRFS Spain
  • Employees
  • ROAD N/A
  • GRFS N/A
  • Industry
  • ROAD Engineering & Construction
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ROAD Industrials
  • GRFS Health Care
  • Exchange
  • ROAD Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • ROAD 5.9B
  • GRFS 6.2B
  • IPO Year
  • ROAD 2018
  • GRFS 2006
  • Fundamental
  • Price
  • ROAD $95.03
  • GRFS $10.85
  • Analyst Decision
  • ROAD Buy
  • GRFS Hold
  • Analyst Count
  • ROAD 4
  • GRFS 1
  • Target Price
  • ROAD $91.00
  • GRFS $10.30
  • AVG Volume (30 Days)
  • ROAD 503.6K
  • GRFS 1.4M
  • Earning Date
  • ROAD 08-07-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • ROAD N/A
  • GRFS N/A
  • EPS Growth
  • ROAD N/A
  • GRFS 132.60
  • EPS
  • ROAD 1.13
  • GRFS 0.53
  • Revenue
  • ROAD $2,189,187,000.00
  • GRFS $8,744,226,659.00
  • Revenue This Year
  • ROAD $56.53
  • GRFS $5.40
  • Revenue Next Year
  • ROAD $13.56
  • GRFS $6.74
  • P/E Ratio
  • ROAD $83.82
  • GRFS $26.22
  • Revenue Growth
  • ROAD 31.49
  • GRFS 9.32
  • 52 Week Low
  • ROAD $51.63
  • GRFS $6.19
  • 52 Week High
  • ROAD $114.74
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • ROAD 35.97
  • GRFS 72.00
  • Support Level
  • ROAD $101.47
  • GRFS $10.59
  • Resistance Level
  • ROAD $103.92
  • GRFS $10.86
  • Average True Range (ATR)
  • ROAD 4.14
  • GRFS 0.30
  • MACD
  • ROAD -1.29
  • GRFS 0.05
  • Stochastic Oscillator
  • ROAD 6.92
  • GRFS 75.78

About ROAD Construction Partners Inc.

Construction Partners Inc operates as a civil infrastructure company. It specializes in the construction and maintenance of roadways. The company through its subsidiaries, provides various products and services to both public and private infrastructure projects, with an emphasis on highways, roads, bridges, airports, and commercial and residential developments. Its operations consist of manufacturing and distributing hot mix asphalt, paving activities, including the construction of roadway base layers and application of asphalt pavement, site development, including the installation of utility and drainage systems, and others. The company has a single segment which predominantly consists of infrastructure and road construction, and operates across various states in the United States.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: